111 related articles for article (PubMed ID: 8286040)
1. Chemoprevention of retroviral infection: success is determined by virus inoculum strength and cellular immunity.
Ruprecht RM; Bronson R
DNA Cell Biol; 1994 Jan; 13(1):59-66. PubMed ID: 8286040
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha and 3'-azido-3'-deoxythymidine are highly synergistic in mice and prevent viremia after acute retrovirus exposure.
Ruprecht RM; Chou TC; Chipty F; Sosa MG; Mullaney S; O'Brien L; Rosas D
J Acquir Immune Defic Syndr (1988); 1990; 3(6):591-600. PubMed ID: 2159992
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with a live retrovirus: the nature of the protective immune response.
Ruprecht RM; Mullaney S; Bernard LD; Gama Sosa MA; Hom RC; Finberg RW
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5558-62. PubMed ID: 2371289
[TBL] [Abstract][Full Text] [Related]
4. New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine: inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens.
Schwendener RA; Gowland P; Horber DH; Zahner R; Schertler A; Schott H
Antiviral Res; 1994 May; 24(1):79-93. PubMed ID: 7944315
[TBL] [Abstract][Full Text] [Related]
5. Murine models for antiretroviral therapy.
Ruprecht RM
Intervirology; 1989; 30 Suppl 1():2-11. PubMed ID: 2540110
[TBL] [Abstract][Full Text] [Related]
6. Protective cellular retroviral immunity requires both CD4+ and CD8+ immune T cells.
Hom RC; Finberg RW; Mullaney S; Ruprecht RM
J Virol; 1991 Jan; 65(1):220-4. PubMed ID: 1898666
[TBL] [Abstract][Full Text] [Related]
7. Suppression of mouse viraemia and retroviral disease by 3'-azido-3'-deoxythymidine.
Ruprecht RM; O'Brien LG; Rossoni LD; Nusinoff-Lehrman S
Nature; 1986 Oct 2-8; 323(6087):467-9. PubMed ID: 3463867
[TBL] [Abstract][Full Text] [Related]
8. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
9. Zidovudine in combination with alpha interferon and interleukin-2 as prophylactic therapy for FeLV-induced immunodeficiency syndrome (FeLV-FAIDS).
Zeidner NS; Rose LM; Mathiason-DuBard CK; Myles MH; Hill DL; Mullins JI; Hoover EA
J Acquir Immune Defic Syndr (1988); 1990; 3(8):787-96. PubMed ID: 2164083
[TBL] [Abstract][Full Text] [Related]
10. Effects of murine leukemia viruses on the function of dendritic cells.
Gabrilovich DI; Roberts MS; Harvey JJ; Botcherby M; Bedford PA; Knight SC
Eur J Immunol; 1993 Nov; 23(11):2932-8. PubMed ID: 8223870
[TBL] [Abstract][Full Text] [Related]
11. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
Sugahara D; Tsuji-Kawahara S; Miyazawa M
J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
[TBL] [Abstract][Full Text] [Related]
12. A notable phenomenon recapitulated. A fusion product of a murine lymphoma cell and a leukemia virus-neutralizing antibody-producer host plasma cell formed spontaneously and secreting the specific antibody continuously.
Sinkovics JG
Acta Microbiol Immunol Hung; 2005; 52(1):1-40. PubMed ID: 15957233
[TBL] [Abstract][Full Text] [Related]
13. Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.
Messer RJ; Dittmer U; Peterson KE; Hasenkrug KJ
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12260-5. PubMed ID: 15297622
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms.
Dittmer U; Brooks DM; Hasenkrug KJ
J Virol; 1998 Aug; 72(8):6554-8. PubMed ID: 9658099
[TBL] [Abstract][Full Text] [Related]
15. Murine retrovirus induces defects in the function of dendritic cells at early stages of infection.
Gabrilovich DI; Patterson S; Harvey JJ; Woods GM; Elsley W; Knight SC
Cell Immunol; 1994 Oct; 158(1):167-81. PubMed ID: 8087863
[TBL] [Abstract][Full Text] [Related]
16. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
BasombrÃo MA; Mayer AM; Pasqualini CD
Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
[TBL] [Abstract][Full Text] [Related]
17. Vaccine protection by subinfectious doses of a live murine leukemia virus.
Rasmussen RA; Sharma PL; Hu Y; Ruprecht RM
Leukemia; 1999 Apr; 13 Suppl 1():S94-5. PubMed ID: 10232377
[No Abstract] [Full Text] [Related]
18. Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infection.
Morrey JD; Warren RP; Okleberry KM; Burger RA; Johnston MI; Sidwell RW
J Acquir Immune Defic Syndr (1988); 1990; 3(5):500-10. PubMed ID: 2157836
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12 restores dendritic cell function and cell-mediated immunity in retrovirus-infected mice.
Williams NJ; Harvey JJ; Duncan I; Booth RF; Knight SC
Cell Immunol; 1998 Feb; 183(2):121-30. PubMed ID: 9606996
[TBL] [Abstract][Full Text] [Related]
20. Correlates of immune protection after vaccination with attenuated live murine leukemia virus.
Ruprecht RM; Hu Y; Liska V; Rasmussen R; Sharma P
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):375-7. PubMed ID: 8882313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
